Loading... Please wait...
  • Sample Pages Request: NPS+ Growth Hormone Deficiency (EU5)
  • The Healthcare Internet of Things: A Network of Opportunities for All (2016) Sample Pages
  • Invoice: The Future of Orphan Drug
  • Invoice: What is Value in Healthcare
  • Hepatitis C: KOL Insight Sample Pages
  • Sample Pages - Chronic Lymphocytic Leukaemia: KOL Insight
  • About FirstWord

    FirstWord is part of the P\S\L Group, a global organisation dedicated to putting information at the service of medicine. The companies and people of the P\S\L Group aim to improve medical care by serving those who need it, those who provide it and those who seek to improve it.

    FirstWord offers several products and services to help Pharma and Medical Technology companies gain a knowledge edge, enabling you to make key business decisions with speed and confidence.

     

    FirstWord Pharma PLUS is a trusted news service that keeps pharmaceutical professionals up-to-date with the latest pharmaceutical industry news and intelligence from across the globe. This personalised news service allows you to monitor and track up to 25 specific compounds/products, companies, medical conditions, and international medical meetings, as well as 15 markets and regulatory bodies, to provide you with the most relevant news and intelligence vital to your needs.

    FirstWord MedTech PLUS, a customisable news service facilitating the discovery of
    the latest news and intelligence, provides unlimited coverage from over 120 medical
    conditions, 32 therapeutic areas, 100 regulatory bodies worldwide, 5,000 products,
    and 2,000 companies.

    FirstWord Dossier Reports provide insight and the latest thinking from industry experts on important trends and the most challenging issues affecting the pharmaceutical industry today. These highly-focused, relevant, up-to-date and actionable intelligence reports deliver information vital for competitive advantage.

    FirstWord Therapy Trends Reports deliver a deep level of insight into the market impact of current and future therapies for the treatment and diagnosis of major medical conditions. These unbiased and continuously updated FirstWord research reports are delivered in two modules: KOL Insight and Consensus Outlook.



    customer.service@firstwordpharma.com

    All Contents Copyright © 2017 Doctor's Guide Publishing Limited All Rights Reserved